{
  "DOI": "10.1007/s10689-017-0038-2",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-017-0038-2",
  "alternative-id": [
    "38"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Felix",
      "given": "Gabriela E. S.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Zheng",
      "given": "Yonglan",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-9936-1599",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Olopade",
      "given": "Olufunmilayo I.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2017,
        9,
        16
      ]
    ],
    "date-time": "2017-09-16T09:25:50Z",
    "timestamp": 1505553950000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        8,
        2
      ]
    ],
    "date-time": "2022-08-02T22:46:19Z",
    "timestamp": 1659480379000
  },
  "funder": [
    {
      "name": "Coordination for the Improvement of Higher Education Personnel (CAPES)"
    },
    {
      "DOI": "10.13039/100000869",
      "doi-asserted-by": "publisher",
      "name": "Susan G. Komen for the Cure"
    },
    {
      "name": "John and Editha Kapoor Charitable Foundation"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        22
      ]
    ],
    "date-time": "2024-04-22T23:14:06Z",
    "timestamp": 1713827646722
  },
  "is-referenced-by-count": 20,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2017,
        9,
        16
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2018,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2017,
            9,
            16
          ]
        ],
        "date-time": "2017-09-16T00:00:00Z",
        "timestamp": 1505520000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-017-0038-2/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-017-0038-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-017-0038-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "471-483",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2017,
        9,
        16
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2017,
        9,
        16
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "38_CR1",
      "unstructured": "WHO (2014) Global status report on noncommunicable diseases 2014. World Health. doi: ISBN 9789241564854"
    },
    {
      "DOI": "10.1186/s13058-016-0759-4",
      "author": "AD Skol",
      "doi-asserted-by": "publisher",
      "first-page": "99",
      "journal-title": "Breast Cancer Res",
      "key": "38_CR2",
      "unstructured": "Skol AD, Sasaki MM, Onel K (2016) The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance. Breast Cancer Res 18:99. doi: 10.1186/s13058-016-0759-4",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1056/NEJMp1500523",
      "author": "FS Collins",
      "doi-asserted-by": "publisher",
      "first-page": "793",
      "journal-title": "N Engl J Med",
      "key": "38_CR3",
      "unstructured": "Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372:793–795. doi: 10.1056/NEJMp1500523",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1146/annurev.genom.9.081307.164359",
      "author": "ER Mardis",
      "doi-asserted-by": "publisher",
      "first-page": "387",
      "journal-title": "Annu Rev Genom Hum Genet",
      "key": "38_CR4",
      "unstructured": "Mardis ER (2008) Next-generation DNA sequencing methods. Annu Rev Genom Hum Genet 9:387–402. doi: 10.1146/annurev.genom.9.081307.164359",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.tig.2007.12.007",
      "author": "ER Mardis",
      "doi-asserted-by": "publisher",
      "first-page": "133",
      "journal-title": "Trends Genet",
      "key": "38_CR5",
      "unstructured": "Mardis ER (2008) The impact of next-generation sequencing technology on genetics. Trends Genet 24:133–141. doi: 10.1016/j.tig.2007.12.007",
      "volume": "24",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.ajhg.2010.03.011",
      "author": "CD Royal",
      "doi-asserted-by": "publisher",
      "first-page": "661",
      "journal-title": "Am J Hum Genet",
      "key": "38_CR6",
      "unstructured": "Royal CD, Novembre J, Fullerton SM et al (2010) Inferring genetic ancestry: opportunities, challenges, and implications. Am J Hum Genet 86:661–673. doi: 10.1016/j.ajhg.2010.03.011",
      "volume": "86",
      "year": "2010"
    },
    {
      "DOI": "10.1126/science.2270482",
      "author": "JM Hall",
      "doi-asserted-by": "publisher",
      "first-page": "1684",
      "journal-title": "Science",
      "key": "38_CR7",
      "unstructured": "Hall JM, Lee MK, Newman B et al (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684–1689. doi: 10.1126/science.2270482",
      "volume": "250",
      "year": "1990"
    },
    {
      "DOI": "10.1126/science.8091231",
      "author": "R Wooster",
      "doi-asserted-by": "publisher",
      "first-page": "2088",
      "journal-title": "Science",
      "key": "38_CR8",
      "unstructured": "Wooster R, Neuhausen S, Mangion J et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088–2090. doi: 10.1126/science.8091231",
      "volume": "265",
      "year": "1994"
    },
    {
      "DOI": "10.1002/cncr.29645",
      "author": "T Pal",
      "doi-asserted-by": "publisher",
      "first-page": "4173",
      "journal-title": "Cancer",
      "key": "38_CR9",
      "unstructured": "Pal T, Bonner D, Cragun D et al (2015) A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer 121:4173–4180. doi: 10.1002/cncr.29645",
      "volume": "121",
      "year": "2015"
    },
    {
      "DOI": "10.1530/ERC-16-0277",
      "author": "RL Milne",
      "doi-asserted-by": "publisher",
      "first-page": "T69",
      "journal-title": "Endocr Relat Cancer",
      "key": "38_CR10",
      "unstructured": "Milne RL, Antoniou AC (2016) Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers. Endocr Relat Cancer 23:T69–T84. doi: 10.1530/ERC-16-0277",
      "volume": "23",
      "year": "2016"
    },
    {
      "DOI": "10.1001/jama.2017.7112",
      "author": "KB Kuchenbaecker",
      "doi-asserted-by": "publisher",
      "first-page": "2402",
      "journal-title": "JAMA",
      "key": "38_CR11",
      "unstructured": "Kuchenbaecker KB, Hopper JL, Barnes DR et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402. doi: 10.1001/jama.2017.7112",
      "volume": "317",
      "year": "2017"
    },
    {
      "key": "38_CR12",
      "unstructured": "Petrucelli N, Daly MB, Feldman GL (2013) BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer"
    },
    {
      "DOI": "10.1038/bjc.2012.31",
      "author": "L Robertson",
      "doi-asserted-by": "publisher",
      "first-page": "1234",
      "journal-title": "Br J Cancer",
      "key": "38_CR13",
      "unstructured": "Robertson L, Hanson H, Seal S et al (2012) BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Br J Cancer 106:1234–1238. doi: 10.1038/bjc.2012.31",
      "volume": "106",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s11033-011-0829-8",
      "author": "W Mahfoudh",
      "doi-asserted-by": "publisher",
      "first-page": "1037",
      "journal-title": "Mol Biol Rep",
      "key": "38_CR14",
      "unstructured": "Mahfoudh W, Bouaouina N, Ahmed S, Ben et al (2012) Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population. Mol Biol Rep 39:1037–1046. doi: 10.1007/s11033-011-0829-8",
      "volume": "39",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s13167-010-0037-y",
      "author": "R Janavičius",
      "doi-asserted-by": "publisher",
      "first-page": "397",
      "journal-title": "EPMA J",
      "key": "38_CR15",
      "unstructured": "Janavičius R (2010) Founder BRCA1/2 mutations in the Europe: Implications for hereditary breast-ovarian cancer prevention and control. EPMA J 1:397–412. doi: 10.1007/s13167-010-0037-y",
      "volume": "1",
      "year": "2010"
    },
    {
      "DOI": "10.1590/S1415-47572014000200009",
      "author": "P Ashton-Prolla",
      "doi-asserted-by": "publisher",
      "first-page": "234",
      "journal-title": "Genet Mol Biol",
      "key": "38_CR16",
      "unstructured": "Ashton-Prolla P, Vargas FR (2014) Prevalence and impact of founder mutations in hereditary breast cancer in Latin America. Genet Mol Biol 37:234–240. doi: 10.1590/S1415-47572014000200009",
      "volume": "37",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10549-015-3293-7",
      "author": "MW Wong-Brown",
      "doi-asserted-by": "publisher",
      "first-page": "71",
      "journal-title": "Breast Cancer Res Treat",
      "key": "38_CR17",
      "unstructured": "Wong-Brown MW, Meldrum CJ, Carpenter JE et al (2015) Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer. Breast Cancer Res Treat 150:71–80. doi: 10.1007/s10549-015-3293-7",
      "volume": "150",
      "year": "2015"
    },
    {
      "DOI": "10.1159/000346593",
      "author": "S Shanmughapriya",
      "doi-asserted-by": "publisher",
      "first-page": "226",
      "journal-title": "Oncology",
      "key": "38_CR18",
      "unstructured": "Shanmughapriya S, Nachiappan V, Natarajaseenivasan K (2013) BRCA1 and BRCA2 mutations in the ovarian cancer population across race and ethnicity: special reference to Asia. Oncology 84:226–232. doi: 10.1159/000346593",
      "volume": "84",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ng1096-188",
      "author": "J Struewing",
      "doi-asserted-by": "publisher",
      "first-page": "198",
      "journal-title": "Nat Genet",
      "key": "38_CR19",
      "unstructured": "Struewing J, Abeliovich D, Peretz T et al (1995) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198–200. doi: 10.1038/ng1096-188",
      "volume": "11",
      "year": "1995"
    },
    {
      "DOI": "10.1056/NEJM199705153362001",
      "author": "JP Struewing",
      "doi-asserted-by": "publisher",
      "first-page": "1401",
      "journal-title": "N Engl J Med",
      "key": "38_CR20",
      "unstructured": "Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401–1408. doi: 10.1056/NEJM199705153362001",
      "volume": "336",
      "year": "1997"
    },
    {
      "DOI": "10.1186/1897-4287-9-12",
      "author": "IP Ewald",
      "doi-asserted-by": "publisher",
      "first-page": "12",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "38_CR21",
      "unstructured": "Ewald IP, Izetti P, Vargas FR et al (2011) Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome. Hered Cancer Clin Pract 9:12. doi: 10.1186/1897-4287-9-12",
      "volume": "9",
      "year": "2011"
    },
    {
      "DOI": "10.1590/S1415-47572012000400009",
      "author": "CV Dillenburg",
      "doi-asserted-by": "publisher",
      "first-page": "599",
      "journal-title": "Genet Mol Biol",
      "key": "38_CR22",
      "unstructured": "Dillenburg CV, Bandeira IC, Tubino TV et al (2012) Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil. Genet Mol Biol 35:599–602. doi: 10.1590/S1415-47572012000400009",
      "volume": "35",
      "year": "2012"
    },
    {
      "DOI": "10.1016/S0084-3954(08)79042-0",
      "author": "EM John",
      "doi-asserted-by": "publisher",
      "first-page": "2869",
      "journal-title": "JAMA",
      "key": "38_CR23",
      "unstructured": "John EM, Miron A, Gong G et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298:2869–2876. doi: 10.1016/S0084-3954(08)79042-0",
      "volume": "298",
      "year": "2007"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-05-0072",
      "author": "JN Weitzel",
      "doi-asserted-by": "publisher",
      "first-page": "1666",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "38_CR24",
      "unstructured": "Weitzel JN, Lagos V, Blazer KR et al (2005) Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 14:1666–1671. doi: 10.1158/1055-9965.EPI-05-0072",
      "volume": "14",
      "year": "2005"
    },
    {
      "DOI": "10.1038/ejhg.2010.203",
      "author": "N Hamel",
      "doi-asserted-by": "publisher",
      "first-page": "300",
      "journal-title": "Eur J Hum Genet",
      "key": "38_CR25",
      "unstructured": "Hamel N, Feng B-J, Foretova L et al (2011) On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations. Eur J Hum Genet 19:300–306. doi: 10.1038/ejhg.2010.203",
      "volume": "19",
      "year": "2011"
    },
    {
      "DOI": "10.1093/hmg/7.5.801",
      "author": "RB Bar-Sade",
      "doi-asserted-by": "publisher",
      "first-page": "801",
      "journal-title": "Hum Mol Genet",
      "key": "38_CR26",
      "unstructured": "Bar-Sade RB, Kruglikova a, Modan B et al (1998) The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Hum Mol Genet 7:801–805. doi: 10.1093/hmg/7.5.801",
      "volume": "7",
      "year": "1998"
    },
    {
      "DOI": "10.1073/pnas.1504447112",
      "author": "FSG Kehdy",
      "doi-asserted-by": "publisher",
      "first-page": "8696",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "38_CR27",
      "unstructured": "Kehdy FSG, Gouveia MH, Machado M et al (2015) Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutations. Proc Natl Acad Sci USA 112:8696–8701. doi: 10.1073/pnas.1504447112",
      "volume": "112",
      "year": "2015"
    },
    {
      "DOI": "10.1590/S1516-84842010005000074",
      "author": "GES Felix",
      "doi-asserted-by": "publisher",
      "first-page": "282",
      "journal-title": "Rev Bras Hematol Hemoter",
      "key": "38_CR28",
      "unstructured": "Felix GES, Abe-Sandes K, Bonfim TM et al (2010) Ancestry informative markers and complete blood count parameters in Brazilian blood donors. Rev Bras Hematol Hemoter 32:282–285. doi: 10.1590/S1516-84842010005000074",
      "volume": "32",
      "year": "2010"
    },
    {
      "DOI": "10.1038/srep09812",
      "author": "MF Lima-Costa",
      "doi-asserted-by": "publisher",
      "first-page": "9812",
      "journal-title": "Sci Rep",
      "key": "38_CR29",
      "unstructured": "Lima-Costa MF, Rodrigues LC, Barreto ML et al (2015) Genomic ancestry and ethnoracial self-classification based on 5,871 community-dwelling Brazilians (The Epigen Initiative). Sci Rep 5:9812. doi: 10.1038/srep09812",
      "volume": "5",
      "year": "2015"
    },
    {
      "DOI": "10.1002/humu.21159",
      "author": "NPC Santos",
      "doi-asserted-by": "publisher",
      "first-page": "184",
      "journal-title": "Hum Mutat",
      "key": "38_CR30",
      "unstructured": "Santos NPC, Ribeiro-Rodrigues EM, Ribeiro-Dos-Santos AKC et al (2010) Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel. Hum Mutat 31:184–190. doi: 10.1002/humu.21159",
      "volume": "31",
      "year": "2010"
    },
    {
      "DOI": "10.1073/pnas.0126614100",
      "author": "FC Parra",
      "doi-asserted-by": "publisher",
      "first-page": "177",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "38_CR31",
      "unstructured": "Parra FC, Amado RC, Lambertucci JR et al (2003) Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 100:177–182. doi: 10.1073/pnas.0126614100",
      "volume": "100",
      "year": "2003"
    },
    {
      "key": "38_CR32",
      "unstructured": "IBGE (2007) IBGE | Memória | publicações | Brasil: 500 anos de povoamento. http://memoria.ibge.gov.br/publicacoes/brasil-500-anos-de-povoamento.html . Accessed 9 May 2016"
    },
    {
      "DOI": "10.1590/S1516-31802005000400007",
      "author": "RM Dufloth",
      "doi-asserted-by": "publisher",
      "first-page": "192",
      "journal-title": "Sao Paulo Med J",
      "key": "38_CR33",
      "unstructured": "Dufloth RM, Carvalho S, Heinrich JK et al (2005) Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history. Sao Paulo Med J 123:192–197. doi: 10.1590/S1516-31802005000400007",
      "volume": "123",
      "year": "2005"
    },
    {
      "DOI": "10.1038/hgv.2014.12",
      "author": "GE Felix",
      "doi-asserted-by": "publisher",
      "first-page": "14012",
      "journal-title": "Hum Genome Var",
      "key": "38_CR34",
      "unstructured": "Felix GE, Abe-Sandes C, Machado-Lopes TM et al (2014) Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population. Hum Genome Var 1:14012. doi: 10.1038/hgv.2014.12",
      "volume": "1",
      "year": "2014"
    },
    {
      "DOI": "10.1590/S0100-879X2009000500009",
      "author": "VF Esteves",
      "doi-asserted-by": "publisher",
      "first-page": "453",
      "journal-title": "Braz J Med Biol Res",
      "key": "38_CR35",
      "unstructured": "Esteves VF, Thuler LCS, Amêndola LC et al (2009) Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil. Braz J Med Biol Res 42:453–457. doi: 10.1590/S0100-879X2009000500009",
      "volume": "42",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10549-006-9378-6",
      "author": "MCB Gomes",
      "doi-asserted-by": "publisher",
      "first-page": "349",
      "journal-title": "Breast Cancer Res Treat",
      "key": "38_CR36",
      "unstructured": "Gomes MCB, Costa MM, Borojevic R et al (2007) Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil. Breast Cancer Res Treat 103:349–353. doi: 10.1007/s10549-006-9378-6",
      "volume": "103",
      "year": "2007"
    },
    {
      "DOI": "10.1186/1471-2350-15-55",
      "author": "FC Silva",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "journal-title": "BMC Med Genet",
      "key": "38_CR37",
      "unstructured": "Silva FC, Lisboa BC, Figueiredo MC et al (2014) Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients. BMC Med Genet 15:55. doi: 10.1186/1471-2350-15-55",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.cancergencyto.2008.03.011",
      "author": "ECB da Costa",
      "doi-asserted-by": "publisher",
      "first-page": "62",
      "journal-title": "Cancer Genet Cytogenet",
      "key": "38_CR38",
      "unstructured": "da Costa ECB, Vargas FR, Moreira AS et al (2008) Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome. Cancer Genet Cytogenet 184:62–66. doi: 10.1016/j.cancergencyto.2008.03.011",
      "volume": "184",
      "year": "2008"
    },
    {
      "author": "Q Gao",
      "first-page": "1233",
      "journal-title": "Am J Hum Genet",
      "key": "38_CR39",
      "unstructured": "Gao Q, Neuhausen S, Cummings S et al (1997) Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. Am J Hum Genet 60:1233–1236",
      "volume": "60",
      "year": "1997"
    },
    {
      "DOI": "10.1001/jama.294.15.1925",
      "author": "R Nanda",
      "doi-asserted-by": "publisher",
      "first-page": "1925",
      "journal-title": "JAMA",
      "key": "38_CR40",
      "unstructured": "Nanda R, Schumm LP, Cummings S et al (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294:1925–1933. doi: 10.1001/jama.294.15.1925",
      "volume": "294",
      "year": "2005"
    },
    {
      "DOI": "10.1002/ijc.27326",
      "author": "JD Fackenthal",
      "doi-asserted-by": "publisher",
      "first-page": "1114",
      "journal-title": "Int J cancer",
      "key": "38_CR41",
      "unstructured": "Fackenthal JD, Zhang J, Zhang B et al (2012) High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients. Int J cancer 131:1114–1123. doi: 10.1002/ijc.27326",
      "volume": "131",
      "year": "2012"
    },
    {
      "DOI": "10.1158/0008-5472.SABCS-09-4078",
      "author": "T Donenberg",
      "doi-asserted-by": "publisher",
      "first-page": "4078",
      "journal-title": "Cancer Res",
      "key": "38_CR42",
      "unstructured": "Donenberg T, Lunn J, Turnquest T et al (2009) High frequency of BRCA1 founder mutations in the Bahamas. Cancer Res 69:4078–4078. doi: 10.1158/0008-5472.SABCS-09-4078",
      "volume": "69",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10549-010-1156-9",
      "author": "T Donenberg",
      "doi-asserted-by": "publisher",
      "first-page": "591",
      "journal-title": "Breast Cancer Res Treat",
      "key": "38_CR43",
      "unstructured": "Donenberg T, Lunn J, Curling D et al (2011) A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas. Breast Cancer Res Treat 125:591–596. doi: 10.1007/s10549-010-1156-9",
      "volume": "125",
      "year": "2011"
    },
    {
      "DOI": "10.1111/cge.12132",
      "author": "M Akbari",
      "doi-asserted-by": "publisher",
      "first-page": "64",
      "journal-title": "Clin Genet",
      "key": "38_CR44",
      "unstructured": "Akbari M, Donenberg T, Lunn J et al (2014) The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas. Clin Genet 85:64–67. doi: 10.1111/cge.12132",
      "volume": "85",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10549-016-3870-4",
      "author": "T Donenberg",
      "doi-asserted-by": "publisher",
      "first-page": "131",
      "journal-title": "Breast Cancer Res Treat",
      "key": "38_CR45",
      "unstructured": "Donenberg T, Ahmed H, Royer R et al (2016) A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago. Breast Cancer Res Treat 159:131–138. doi: 10.1007/s10549-016-3870-4",
      "volume": "159",
      "year": "2016"
    },
    {
      "DOI": "10.1186/1897-4287-12-11",
      "author": "JEL Hernández",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "38_CR46",
      "unstructured": "Hernández JEL, Llacuachaqui M, Palacio GV et al (2014) Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Medellín, Colombia. Hered Cancer Clin Pract 12:11. doi: 10.1186/1897-4287-12-11",
      "volume": "12",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10549-006-9370-1",
      "author": "D Torres",
      "doi-asserted-by": "publisher",
      "first-page": "225",
      "journal-title": "Breast Cancer Res Treat",
      "key": "38_CR47",
      "unstructured": "Torres D, Rashid MU, Gil F et al (2007) High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia. Breast Cancer Res Treat 103:225–232. doi: 10.1007/s10549-006-9370-1",
      "volume": "103",
      "year": "2007"
    },
    {
      "DOI": "10.1038/s41598-017-05056-y",
      "author": "D Torres",
      "doi-asserted-by": "publisher",
      "first-page": "4713",
      "journal-title": "Sci Rep",
      "key": "38_CR48",
      "unstructured": "Torres D, Bermejo JL, Rashid MU et al (2017) Prevalence and penetrance of BRCA1 and BRCA2 germline mutations in Colombian breast cancer patients. Sci Rep 7:4713. doi: 10.1038/s41598-017-05056-y",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.1002/cncr.24200",
      "author": "MJ Hall",
      "doi-asserted-by": "publisher",
      "first-page": "2222",
      "journal-title": "Cancer",
      "key": "38_CR49",
      "unstructured": "Hall MJ, Reid JE, Burbidge LA et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115:2222–2233. doi: 10.1002/cncr.24200",
      "volume": "115",
      "year": "2009"
    },
    {
      "DOI": "10.1073/pnas.83.19.7391",
      "author": "TP Dryja",
      "doi-asserted-by": "crossref",
      "first-page": "7391",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "38_CR50",
      "unstructured": "Dryja TP, Rapaport JM, Joyce JM, Petersen RA (1986) Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas. Proc Natl Acad Sci USA 83:7391–7394",
      "volume": "83",
      "year": "1986"
    },
    {
      "DOI": "10.1038/323643a0",
      "author": "SH Friend",
      "doi-asserted-by": "publisher",
      "first-page": "643",
      "journal-title": "Nature",
      "key": "38_CR51",
      "unstructured": "Friend SH, Bernards R, Rogelj S et al (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643–646. doi: 10.1038/323643a0",
      "volume": "323",
      "year": "1986"
    },
    {
      "DOI": "10.1126/science.2885916",
      "author": "YK Fung",
      "doi-asserted-by": "crossref",
      "first-page": "1657",
      "journal-title": "Science",
      "key": "38_CR52",
      "unstructured": "Fung YK, Murphree AL, T’Ang A et al (1987) Structural evidence for the authenticity of the human retinoblastoma gene. Science 236:1657–1661",
      "volume": "236",
      "year": "1987"
    },
    {
      "DOI": "10.1126/science.3823889",
      "author": "WH Lee",
      "doi-asserted-by": "crossref",
      "first-page": "1394",
      "journal-title": "Science",
      "key": "38_CR53",
      "unstructured": "Lee WH, Bookstein R, Hong F et al (1987) Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235:1394–1399",
      "volume": "235",
      "year": "1987"
    },
    {
      "DOI": "10.1128/JVI.31.2.472-483.1979",
      "author": "M Kress",
      "doi-asserted-by": "crossref",
      "first-page": "472",
      "journal-title": "J Virol",
      "key": "38_CR54",
      "unstructured": "Kress M, May E, Cassingena R, May P (1979) Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum. J Virol 31:472–483",
      "volume": "31",
      "year": "1979"
    },
    {
      "DOI": "10.1038/278261a0",
      "author": "DP Lane",
      "doi-asserted-by": "crossref",
      "first-page": "261",
      "journal-title": "Nature",
      "key": "38_CR55",
      "unstructured": "Lane DP, Crawford LV (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261–263",
      "volume": "278",
      "year": "1979"
    },
    {
      "DOI": "10.1016/0092-8674(79)90293-9",
      "author": "DI Linzer",
      "doi-asserted-by": "crossref",
      "first-page": "43",
      "journal-title": "Cell",
      "key": "38_CR56",
      "unstructured": "Linzer DI, Levine AJ (1979) Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17:43–52",
      "volume": "17",
      "year": "1979"
    },
    {
      "DOI": "10.1038/328614a0",
      "doi-asserted-by": "publisher",
      "key": "38_CR57",
      "unstructured": "Bodmer WF, Bailey CJ, Bodmer J et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328:614–616. doi: 10.1038/328614a0"
    },
    {
      "DOI": "10.1126/science.3479843",
      "author": "M Leppert",
      "doi-asserted-by": "crossref",
      "first-page": "1411",
      "journal-title": "Science",
      "key": "38_CR58",
      "unstructured": "Leppert M, Dobbs M, Scambler P et al (1987) The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 238:1411–1413",
      "volume": "238",
      "year": "1987"
    },
    {
      "DOI": "10.1038/ng1193-279",
      "author": "A Lindblom",
      "doi-asserted-by": "publisher",
      "first-page": "279",
      "journal-title": "Nat Genet",
      "key": "38_CR59",
      "unstructured": "Lindblom A, Tannergård P, Werelius B, Nordenskjöld M (1993) Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 5:279–282. doi: 10.1038/ng1193-279",
      "volume": "5",
      "year": "1993"
    },
    {
      "DOI": "10.1016/0092-8674(93)90546-3",
      "author": "R Fishel",
      "doi-asserted-by": "crossref",
      "first-page": "1027",
      "journal-title": "Cell",
      "key": "38_CR60",
      "unstructured": "Fishel R, Lescoe MK, Rao MR et al (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027–1038",
      "volume": "75",
      "year": "1993"
    },
    {
      "DOI": "10.1016/0092-8674(93)90330-S",
      "author": "FS Leach",
      "doi-asserted-by": "crossref",
      "first-page": "1215",
      "journal-title": "Cell",
      "key": "38_CR61",
      "unstructured": "Leach FS, Nicolaides NC, Papadopoulos N et al (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215–1225",
      "volume": "75",
      "year": "1993"
    },
    {
      "DOI": "10.1038/368258a0",
      "author": "CE Bronner",
      "doi-asserted-by": "publisher",
      "first-page": "258",
      "journal-title": "Nature",
      "key": "38_CR62",
      "unstructured": "Bronner CE, Baker SM, Morrison PT et al (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368:258–261. doi: 10.1038/368258a0",
      "volume": "368",
      "year": "1994"
    },
    {
      "DOI": "10.1126/science.8128251",
      "author": "N Papadopoulos",
      "doi-asserted-by": "crossref",
      "first-page": "1625",
      "journal-title": "Science",
      "key": "38_CR63",
      "unstructured": "Papadopoulos N, Nicolaides NC, Wei YF et al (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625–1629",
      "volume": "263",
      "year": "1994"
    },
    {
      "DOI": "10.1126/science.1439824",
      "author": "LA Cannon-Albright",
      "doi-asserted-by": "crossref",
      "first-page": "1148",
      "journal-title": "Science",
      "key": "38_CR64",
      "unstructured": "Cannon-Albright LA, Goldgar DE, Meyer LJ et al (1992) Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 258:1148–1152",
      "volume": "258",
      "year": "1992"
    },
    {
      "DOI": "10.1038/366704a0",
      "author": "M Serrano",
      "doi-asserted-by": "publisher",
      "first-page": "704",
      "journal-title": "Nature",
      "key": "38_CR65",
      "unstructured": "Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704–707. doi: 10.1038/366704a0",
      "volume": "366",
      "year": "1993"
    },
    {
      "DOI": "10.1038/ng0994-22",
      "author": "A Kamb",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "journal-title": "Nat Genet",
      "key": "38_CR66",
      "unstructured": "Kamb A, Shattuck-Eidens D, Eeles R et al (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8:23–26. doi: 10.1038/ng0994-22",
      "volume": "8",
      "year": "1994"
    },
    {
      "DOI": "10.1126/science.8153634",
      "author": "A Kamb",
      "doi-asserted-by": "crossref",
      "first-page": "436",
      "journal-title": "Science",
      "key": "38_CR67",
      "unstructured": "Kamb A, Gruis NA, Weaver-Feldhaus J et al (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436–440",
      "volume": "264",
      "year": "1994"
    },
    {
      "DOI": "10.1016/0888-7543(95)80212-5",
      "author": "G Berx",
      "doi-asserted-by": "crossref",
      "first-page": "281",
      "journal-title": "Genomics",
      "key": "38_CR68",
      "unstructured": "Berx G, Staes K, van Hengel J et al (1995) Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 26:281–289",
      "volume": "26",
      "year": "1995"
    },
    {
      "DOI": "10.1016/0888-7543(91)90313-4",
      "author": "LZ Chen",
      "doi-asserted-by": "crossref",
      "first-page": "308",
      "journal-title": "Genomics",
      "key": "38_CR69",
      "unstructured": "Chen LZ, Harris PC, Apostolou S et al (1991) A refined physical map of the long arm of human chromosome 16. Genomics 10:308–312",
      "volume": "10",
      "year": "1991"
    },
    {
      "DOI": "10.1073/pnas.1007983107",
      "author": "T Walsh",
      "doi-asserted-by": "publisher",
      "first-page": "12629",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "38_CR70",
      "unstructured": "Walsh T, Lee MK, Casadei S et al (2010) Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci USA 107:12629–12633. doi: 10.1073/pnas.1007983107",
      "volume": "107",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10549-014-3195-0",
      "author": "JE Churpek",
      "doi-asserted-by": "publisher",
      "journal-title": "Breast Cancer Res Treat",
      "key": "38_CR71",
      "unstructured": "Churpek JE, Walsh T, Zheng Y et al (2014) Inherited predisposition to breast cancer among African American women. Breast Cancer Res Treat. doi: 10.1007/s10549-014-3195-0",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10549-006-9320-y",
      "author": "C Cybulski",
      "doi-asserted-by": "publisher",
      "first-page": "119",
      "journal-title": "Breast Cancer Res Treat",
      "key": "38_CR72",
      "unstructured": "Cybulski C, Wokołorczyk D, Huzarski T et al (2007) A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Breast Cancer Res Treat 102:119–122. doi: 10.1007/s10549-006-9320-y",
      "volume": "102",
      "year": "2007"
    },
    {
      "DOI": "10.1086/426403",
      "author": "C Cybulski",
      "doi-asserted-by": "publisher",
      "first-page": "1131",
      "journal-title": "Am J Hum Genet",
      "key": "38_CR73",
      "unstructured": "Cybulski C, Górski B, Huzarski T et al (2004) CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75:1131–1135. doi: 10.1086/426403",
      "volume": "75",
      "year": "2004"
    },
    {
      "DOI": "10.1038/ng879",
      "author": "H Meijers-Heijboer",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "journal-title": "Nat Genet",
      "key": "38_CR74",
      "unstructured": "Meijers-Heijboer H, van den Ouweland A, Klijn J et al (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55–59. doi: 10.1038/ng879",
      "volume": "31",
      "year": "2002"
    },
    {
      "DOI": "10.1186/bcr933",
      "author": "DM Friedrichsen",
      "doi-asserted-by": "publisher",
      "first-page": "R629-35",
      "journal-title": "Breast Cancer Res",
      "key": "38_CR75",
      "unstructured": "Friedrichsen DM, Malone KE, Doody DR et al (2004) Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women. Breast Cancer Res 6:R629-35. doi: 10.1186/bcr933",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1002/ijc.20439",
      "author": "LH Mateus Pereira",
      "doi-asserted-by": "publisher",
      "first-page": "541",
      "journal-title": "Int J cancer",
      "key": "38_CR76",
      "unstructured": "Mateus Pereira LH, Sigurdson AJ, Doody MM et al (2004) CHEK2:1100delC and female breast cancer in the United States. Int J cancer 112:541–543. doi: 10.1002/ijc.20439",
      "volume": "112",
      "year": "2004"
    },
    {
      "DOI": "10.1056/NEJMsr1501341",
      "doi-asserted-by": "crossref",
      "key": "38_CR77",
      "unstructured": "Easton DF, Pharoah PDP, Antoniou AC et al. (2015) Gene-panel sequencing and the prediction of breast-cancer risk. 23:2243–2257"
    },
    {
      "DOI": "10.1001/jama.2014.12483",
      "author": "M-C King",
      "doi-asserted-by": "publisher",
      "first-page": "1091",
      "journal-title": "JAMA",
      "key": "38_CR78",
      "unstructured": "King M-C, Levy-Lahad E, Lahad A et al (2014) Population-Based Screening for BRCA1 and BRCA2. JAMA 312:1091. doi: 10.1001/jama.2014.12483",
      "volume": "312",
      "year": "2014"
    },
    {
      "DOI": "10.1093/jnci/djs264",
      "author": "CA Clarke",
      "doi-asserted-by": "publisher",
      "first-page": "1094",
      "journal-title": "J Natl Cancer Inst",
      "key": "38_CR79",
      "unstructured": "Clarke CA, Keegan THM, Yang J et al (2012) Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst 104:1094–1101. doi: 10.1093/jnci/djs264",
      "volume": "104",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2008.19.6873",
      "author": "D Huo",
      "doi-asserted-by": "publisher",
      "first-page": "4515",
      "journal-title": "J Clin Oncol",
      "key": "38_CR80",
      "unstructured": "Huo D, Ikpatt F, Khramtsov A et al (2009) Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 27:4515–4521. doi: 10.1200/JCO.2008.19.6873",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1001/jamaoncol.2017.0595",
      "author": "D Huo",
      "doi-asserted-by": "publisher",
      "journal-title": "JAMA Oncol",
      "key": "38_CR81",
      "unstructured": "Huo D, Hu H, Rhie SK et al (2017) Comparison of breast cancer molecular features and survival by African and European Ancestry in the cancer genome atlas. JAMA Oncol. doi: 10.1001/jamaoncol.2017.0595",
      "year": "2017"
    },
    {
      "DOI": "10.1200/jco.2010.28.15_suppl.1602",
      "author": "KA Adeniji",
      "doi-asserted-by": "crossref",
      "first-page": "1602",
      "journal-title": "Nigeria. J Clin Oncol",
      "key": "38_CR82",
      "unstructured": "Adeniji KA, Huo D, Khramtsov A et al. (2010) Molecular profiles of breast cancer in Ilorin, Nigeria. J Clin Oncol 28:1602",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.breast.2007.07.017",
      "author": "J Kurebayashi",
      "doi-asserted-by": "crossref",
      "first-page": "S72",
      "journal-title": "Breast",
      "key": "38_CR83",
      "unstructured": "Kurebayashi J, Moriya T, Ishida T et al. (2007) The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast 16:S72–S77",
      "volume": "16",
      "year": "2007"
    },
    {
      "DOI": "10.1073/pnas.0932692100",
      "author": "T Sorlie",
      "doi-asserted-by": "publisher",
      "first-page": "8418",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "38_CR84",
      "unstructured": "Sorlie T, Tibshirani R, Parker J et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418–8423. doi: 10.1073/pnas.0932692100",
      "volume": "100",
      "year": "2003"
    },
    {
      "author": "TA Grushko",
      "first-page": "1481",
      "journal-title": "Cancer Res",
      "key": "38_CR85",
      "unstructured": "Grushko TA, Blackwood MA, Schumm PL et al (2002) Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. Cancer Res 62:1481–1488",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2010.33.6446",
      "author": "E Lee",
      "doi-asserted-by": "publisher",
      "first-page": "4373",
      "journal-title": "J Clin Oncol",
      "key": "38_CR86",
      "unstructured": "Lee E, McKean-Cowdin R, Ma H et al (2011) Characteristics of triple-negative breast cancer in patients with a BRCA1 Mutation: results from a population-based study of young women. J Clin Oncol 29:4373–4380. doi: 10.1200/JCO.2010.33.6446",
      "volume": "29",
      "year": "2011"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-11-0775",
      "author": "N Mavaddat",
      "doi-asserted-by": "publisher",
      "first-page": "134",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "38_CR87",
      "unstructured": "Mavaddat N, Barrowdale D, Andrulis IL et al (2012) Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev 21:134–147. doi: 10.1158/1055-9965.EPI-11-0775",
      "volume": "21",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2015.65.0747",
      "author": "N Tung",
      "doi-asserted-by": "publisher",
      "first-page": "1460",
      "journal-title": "J Clin Oncol",
      "key": "38_CR88",
      "unstructured": "Tung N, Lin NU, Kidd J et al (2016) Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol 34:1460–1468. doi: 10.1200/JCO.2015.65.0747",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.1200/JCO.2008.17.5869",
      "author": "D Huo",
      "doi-asserted-by": "publisher",
      "first-page": "1184",
      "journal-title": "J Clin Oncol",
      "key": "38_CR89",
      "unstructured": "Huo D, Senie RT, Daly M et al (2009) Prediction of BRCA mutations using the BRCAPRO model in clinic-based African American, Hispanic, and other minority families in the United States. J Clin Oncol 27:1184–1190. doi: 10.1200/JCO.2008.17.5869",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1136/jmedgenet-2012-101415",
      "author": "C Fischer",
      "doi-asserted-by": "publisher",
      "first-page": "360",
      "journal-title": "J Med Genet",
      "key": "38_CR90",
      "unstructured": "Fischer C, Kuchenbäcker K, Engel C et al (2013) Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium. J Med Genet 50:360–367. doi: 10.1136/jmedgenet-2012-101415",
      "volume": "50",
      "year": "2013"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-13-1364",
      "author": "EM J. C",
      "doi-asserted-by": "publisher",
      "first-page": "1689",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "38_CR91",
      "unstructured": "J. C EM, C S-C, G. P (2014) Recent BRCAPRO upgrades significantly improve calibration. Cancer Epidemiol Biomarkers Prev 23:1689–1695. doi: 10.1158/1055-9965.EPI-13-1364",
      "volume": "23",
      "year": "2014"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-08-1090",
      "author": "AW Kurian",
      "doi-asserted-by": "publisher",
      "first-page": "1084",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "38_CR92",
      "unstructured": "Kurian AW, Gong GD, John EM et al (2009) Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 18:1084–1091. doi: 10.1158/1055-9965.EPI-08-1090",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.2006.05.5889",
      "author": "MJ Hall",
      "doi-asserted-by": "publisher",
      "first-page": "2197",
      "journal-title": "J Clin Oncol",
      "key": "38_CR93",
      "unstructured": "Hall MJ, Olopade OI (2006) Disparities in genetic testing: thinking outside the BRCA box. J Clin Oncol 24:2197–2203. doi: 10.1200/JCO.2006.05.5889",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1001/jama.293.14.1783",
      "author": "M Hall",
      "doi-asserted-by": "publisher",
      "first-page": "1783",
      "journal-title": "JAMA",
      "key": "38_CR94",
      "unstructured": "Hall M, Olopade OI (2005) Confronting genetic testing disparities: knowledge is power. JAMA 293:1783–1785. doi: 10.1001/jama.293.14.1783",
      "volume": "293",
      "year": "2005"
    },
    {
      "DOI": "10.1038/35101031",
      "author": "G Knudson a",
      "doi-asserted-by": "publisher",
      "first-page": "157",
      "journal-title": "Nat Rev Cancer",
      "key": "38_CR95",
      "unstructured": "Knudson a G (2001) Two genetic hits (more or less) to cancer. Nat Rev Cancer 1:157–162. doi: 10.1038/35101031",
      "volume": "1",
      "year": "2001"
    },
    {
      "DOI": "10.1371/journal.pgen.1003828",
      "author": "M-C King",
      "doi-asserted-by": "publisher",
      "first-page": "e1003828",
      "journal-title": "PLoS Genet",
      "key": "38_CR96",
      "unstructured": "King M-C (2013) Evidence is evidence: an interview with Mary-Claire King. Interviewed by Jane Gitschier. PLoS Genet 9:e1003828. doi: 10.1371/journal.pgen.1003828",
      "volume": "9",
      "year": "2013"
    },
    {
      "DOI": "10.1016/S1470-2045(10)70273-4",
      "author": "JB Harford",
      "doi-asserted-by": "publisher",
      "first-page": "306",
      "journal-title": "Lancet Oncol",
      "key": "38_CR97",
      "unstructured": "Harford JB (2011) Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all. Lancet Oncol 12:306–312. doi: 10.1016/S1470-2045(10)70273-4",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1200/jco.2013.31.15_suppl.1506",
      "doi-asserted-by": "crossref",
      "key": "38_CR98",
      "unstructured": "Guindalini Rodrigo Santa Cruz, Huang Yi-Ching, Obeid Elias, Patrick-Miller Linda, Bradbury Angela R., Marion S, Verp, Susan Hong, Kristen Wroblewski, Hiroyuki Abe, Greg S. Karczmar, (2013) Gillian Newstead OIO Breast cancer surveillance in high-risk women with magnetic resonance imaging every 6 months. | 2013 ASCO Annual Meeting | Abstracts | Meeting Library. J Clin Oncol 31, (suppl; abstr 1506). http://meetinglibrary.asco.org/content/114172-132 . Accessed 30 Dec 2015"
    },
    {
      "DOI": "10.1016/S0140-6736(13)60228-7",
      "author": "T Lancet",
      "doi-asserted-by": "publisher",
      "first-page": "423",
      "journal-title": "Lancet (Lond Engl)",
      "key": "38_CR99",
      "unstructured": "Lancet T (2013) The failure of cancer medicine?. Lancet (Lond Engl) 381:423. doi: 10.1016/S0140-6736(13)60228-7",
      "volume": "381",
      "year": "2013"
    },
    {
      "DOI": "10.3322/caac.21271",
      "author": "B Daly",
      "doi-asserted-by": "publisher",
      "first-page": "221",
      "journal-title": "CA Cancer J Clin",
      "key": "38_CR100",
      "unstructured": "Daly B, Olopade OI (2015) A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin 65:221–238. doi: 10.3322/caac.21271",
      "volume": "65",
      "year": "2015"
    },
    {
      "DOI": "10.1186/1756-9966-29-82",
      "author": "SS Ibrahim",
      "doi-asserted-by": "publisher",
      "first-page": "82",
      "journal-title": "J Exp Clin Cancer Res",
      "key": "38_CR101",
      "unstructured": "Ibrahim SS, Hafez EE, Hashishe MM (2010) Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection. J Exp Clin Cancer Res 29:82. doi: 10.1186/1756-9966-29-82",
      "volume": "29",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10549-012-2136-z",
      "author": "J Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "889",
      "journal-title": "Breast Cancer Res Treat",
      "key": "38_CR102",
      "unstructured": "Zhang J, Fackenthal JD, Zheng Y et al (2012) Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry. Breast Cancer Res Treat 134:889–894. doi: 10.1007/s10549-012-2136-z",
      "volume": "134",
      "year": "2012"
    },
    {
      "DOI": "10.1002/ijc.20186",
      "author": "MD Reeves",
      "doi-asserted-by": "publisher",
      "first-page": "677",
      "journal-title": "Int J Cancer",
      "key": "38_CR103",
      "unstructured": "Reeves MD, Yawitch TM, van der Merwe NC et al (2004) BRCA1 mutations in South African breast and/or ovarian cancer families: Evidence of a novel founder mutation in Afrikaner families. Int J Cancer 110:677–682. doi: 10.1002/ijc.20186",
      "volume": "110",
      "year": "2004"
    },
    {
      "DOI": "10.1002/cncr.11019",
      "author": "OI Olopade",
      "doi-asserted-by": "publisher",
      "first-page": "236",
      "journal-title": "Cancer",
      "key": "38_CR104",
      "unstructured": "Olopade OI, Fackenthal JD, Dunston G et al (2003) Breast cancer genetics in African Americans. Cancer 97:236–245. doi: 10.1002/cncr.11019",
      "volume": "97",
      "year": "2003"
    },
    {
      "DOI": "10.1158/1055-9965.1794.13.11",
      "author": "T Pal",
      "doi-asserted-by": "crossref",
      "first-page": "1794",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "38_CR105",
      "unstructured": "Pal T, Permuth-Wey J, Holtje T, Sutphen R (2004) BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Cancer Epidemiol Biomarkers Prev 13:1794–1799",
      "volume": "13",
      "year": "2004"
    },
    {
      "DOI": "10.1186/2193-1801-1-20",
      "author": "AR Solano",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "journal-title": "Springerplus",
      "key": "38_CR106",
      "unstructured": "Solano AR, Aceto GM, Delettieres D et al (2012) BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin. Springerplus 1:20. doi: 10.1186/2193-1801-1-20",
      "volume": "1",
      "year": "2012"
    },
    {
      "DOI": "10.1111/cge.12602",
      "author": "M Trottier",
      "doi-asserted-by": "publisher",
      "first-page": "328",
      "journal-title": "Clin Genet",
      "key": "38_CR107",
      "unstructured": "Trottier M, Lunn J, Butler R et al (2016) Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas. Clin Genet 89:328–331. doi: 10.1111/cge.12602",
      "volume": "89",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s10689-012-9551-5",
      "author": "MAM Moreira",
      "doi-asserted-by": "publisher",
      "first-page": "657",
      "journal-title": "Fam Cancer",
      "key": "38_CR108",
      "unstructured": "Moreira MAM, Bobrovnitchaia IG, Lima MAFD et al (2012) Portuguese c.156_157insAlu BRCA2 founder mutation: gastrointestinal and tongue neoplasias may be part of the phenotype. Fam Cancer 11:657–660. doi: 10.1007/s10689-012-9551-5",
      "volume": "11",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.cancergencyto.2005.08.019",
      "author": "L Jara",
      "doi-asserted-by": "publisher",
      "first-page": "36",
      "journal-title": "Cancer Genet Cytogenet",
      "key": "38_CR109",
      "unstructured": "Jara L, Ampuero S, Santibáñez E et al (2006) BRCA1 and BRCA2 mutations in a South American population. Cancer Genet Cytogenet 166:36–45. doi: 10.1016/j.cancergencyto.2005.08.019",
      "volume": "166",
      "year": "2006"
    },
    {
      "author": "L Jara",
      "first-page": "1113",
      "journal-title": "Rev médica Chile",
      "key": "38_CR110",
      "unstructured": "Jara L, Ampuero S, Seccia L et al (2002) Frequency of the 185delAG mutation in the BRCA1 gene in Chilean healthy women with family history of breast cancer. Rev médica Chile 130:1113–1123",
      "volume": "130",
      "year": "2002"
    },
    {
      "DOI": "10.1111/j.1399-0004.2011.01774.x",
      "author": "GA Gutiérrez Espeleta",
      "doi-asserted-by": "publisher",
      "first-page": "484",
      "journal-title": "Clin Genet",
      "key": "38_CR111",
      "unstructured": "Gutiérrez Espeleta GA, Llacuachaqui M, García-Jiménez L et al (2012) BRCA1 and BRCA2 mutations among familial breast cancer patients from Costa Rica. Clin Genet 82:484–488. doi: 10.1111/j.1399-0004.2011.01774.x",
      "volume": "82",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10689-008-9187-7",
      "author": "RC Rodriguez",
      "doi-asserted-by": "publisher",
      "first-page": "275",
      "journal-title": "Fam Cancer",
      "key": "38_CR112",
      "unstructured": "Rodriguez RC, Esperon AA, Ropero R et al (2008) Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba. Fam Cancer 7:275–279. doi: 10.1007/s10689-008-9187-7",
      "volume": "7",
      "year": "2008"
    },
    {
      "DOI": "10.1086/302099",
      "author": "PN Tonin",
      "doi-asserted-by": "publisher",
      "first-page": "1341",
      "journal-title": "Am J Hum Genet",
      "key": "38_CR113",
      "unstructured": "Tonin PN, Mes-Masson AM, Futreal PA et al (1998) Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 63:1341–1351. doi: 10.1086/302099",
      "volume": "63",
      "year": "1998"
    },
    {
      "DOI": "10.1002/cncr.29058",
      "author": "C Villarreal-Garza",
      "doi-asserted-by": "publisher",
      "first-page": "372",
      "journal-title": "Cancer",
      "key": "38_CR114",
      "unstructured": "Villarreal-Garza C, Alvarez-Gómez RM, Pérez-Plasencia C et al (2015) Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico. Cancer 121:372–378. doi: 10.1002/cncr.29058",
      "volume": "121",
      "year": "2015"
    },
    {
      "DOI": "10.1111/cge.12505",
      "author": "J Abugattas",
      "doi-asserted-by": "publisher",
      "first-page": "371",
      "journal-title": "Clin Genet",
      "key": "38_CR115",
      "unstructured": "Abugattas J, Llacuachaqui M, Allende YS et al (2015) Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru. Clin Genet 88:371–375. doi: 10.1111/cge.12505",
      "volume": "88",
      "year": "2015"
    },
    {
      "author": "E Levy-Lahad",
      "first-page": "1059",
      "journal-title": "Am J Hum Genet",
      "key": "38_CR116",
      "unstructured": "Levy-Lahad E, Catane R, Eisenberg S et al (1997) Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet 60:1059–1067",
      "volume": "60",
      "year": "1997"
    },
    {
      "DOI": "10.1007/s10549-011-1596-x",
      "author": "J Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "421",
      "journal-title": "Breast Cancer Res Treat",
      "key": "38_CR117",
      "unstructured": "Zhang J, Pei R, Pang Z et al (2012) Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. Breast Cancer Res Treat 132:421–428. doi: 10.1007/s10549-011-1596-x",
      "volume": "132",
      "year": "2012"
    },
    {
      "DOI": "10.1002/humu.9083",
      "author": "X Zhi",
      "doi-asserted-by": "publisher",
      "first-page": "474",
      "journal-title": "Hum Mutat",
      "key": "38_CR118",
      "unstructured": "Zhi X, Szabo C, Chopin S et al (2002) BRCA1 and BRCA2 sequence variants in Chinese breast cancer families. Hum Mutat 20:474. doi: 10.1002/humu.9083",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s10549-007-9708-3",
      "author": "W-F Li",
      "doi-asserted-by": "publisher",
      "first-page": "99",
      "journal-title": "Breast Cancer Res Treat",
      "key": "38_CR119",
      "unstructured": "Li W-F, Hu Z, Rao N-Y et al (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 110:99–109. doi: 10.1007/s10549-007-9708-3",
      "volume": "110",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.cancergencyto.2003.09.020",
      "author": "A Hadjisavvas",
      "doi-asserted-by": "publisher",
      "first-page": "152",
      "journal-title": "Cancer Genet Cytogenet",
      "key": "38_CR120",
      "unstructured": "Hadjisavvas A, Charalambous E, Adamou A et al (2004) Hereditary breast and ovarian cancer in Cyprus: identification of a founder BRCA2 mutation. Cancer Genet Cytogenet 151:152–156. doi: 10.1016/j.cancergencyto.2003.09.020",
      "volume": "151",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s12038-009-0048-9",
      "author": "K Vaidyanathan",
      "doi-asserted-by": "crossref",
      "first-page": "415",
      "journal-title": "J Biosci",
      "key": "38_CR121",
      "unstructured": "Vaidyanathan K, Lakhotia S, Ravishankar HM et al (2009) BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation. J Biosci 34:415–422",
      "volume": "34",
      "year": "2009"
    },
    {
      "DOI": "10.1002/humu.9082",
      "author": "S Saxena",
      "doi-asserted-by": "publisher",
      "first-page": "473",
      "journal-title": "Hum Mutat",
      "key": "38_CR122",
      "unstructured": "Saxena S, Szabo CI, Chopin S et al (2002) BRCA1 and BRCA2 in Indian breast cancer patients. Hum Mutat 20:473–474. doi: 10.1002/humu.9082",
      "volume": "20",
      "year": "2002"
    },
    {
      "author": "M Sekine",
      "first-page": "3144",
      "journal-title": "Clin Cancer Res",
      "key": "38_CR123",
      "unstructured": "Sekine M, Nagata H, Tsuji S et al (2001) Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res 7:3144–3150",
      "volume": "7",
      "year": "2001"
    },
    {
      "DOI": "10.1086/342506",
      "author": "A Liede",
      "doi-asserted-by": "crossref",
      "first-page": "595",
      "journal-title": "Am J Hum Genet",
      "key": "38_CR124",
      "unstructured": "Liede A, Malik IA, Aziz Z et al (2002) Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet 71:595–606",
      "volume": "71",
      "year": "2002"
    },
    {
      "DOI": "10.1038/ejhg.2012.124",
      "author": "Y Laitman",
      "doi-asserted-by": "publisher",
      "first-page": "212",
      "journal-title": "Eur J Hum Genet",
      "key": "38_CR125",
      "unstructured": "Laitman Y, Feng B-J, Zamir IM et al (2013) Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations. Eur J Hum Genet 21:212–216. doi: 10.1038/ejhg.2012.124",
      "volume": "21",
      "year": "2013"
    },
    {
      "DOI": "10.1093/hmg/7.5.801",
      "author": "RB Bar-Sade",
      "doi-asserted-by": "crossref",
      "first-page": "801",
      "journal-title": "Hum Mol Genet",
      "key": "38_CR126",
      "unstructured": "Bar-Sade RB, Kruglikova A, Modan B et al (1998) The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Hum Mol Genet 7:801–805",
      "volume": "7",
      "year": "1998"
    },
    {
      "DOI": "10.1111/j.1399-0004.2010.01545.x",
      "author": "O Ginsburg",
      "doi-asserted-by": "publisher",
      "first-page": "89",
      "journal-title": "Clin Genet",
      "key": "38_CR127",
      "unstructured": "Ginsburg O, Dinh N, To T et al (2011) Family history, BRCA mutations and breast cancer in Vietnamese women. Clin Genet 80:89–92. doi: 10.1111/j.1399-0004.2010.01545.x",
      "volume": "80",
      "year": "2011"
    },
    {
      "DOI": "10.1002/(SICI)1097-0215(19980729)77:3\u003c354::AID-IJC8\u003e3.0.CO;2-N",
      "author": "TM Wagner",
      "doi-asserted-by": "crossref",
      "first-page": "354",
      "journal-title": "Int J cancer",
      "key": "38_CR128",
      "unstructured": "Wagner TM, Möslinger RA, Muhr D et al (1998) BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int J cancer 77:354–360",
      "volume": "77",
      "year": "1998"
    },
    {
      "DOI": "10.1016/S0959-8049(97)84398-5",
      "author": "T Wagner",
      "doi-asserted-by": "publisher",
      "first-page": "S7",
      "journal-title": "Eur J Cancer",
      "key": "38_CR129",
      "unstructured": "Wagner T, Möslinger R, Muhr D et al (1997) Founding BRCA1 mutations in Austrian HBOC families. Eur J Cancer 33:S7. doi: 10.1016/S0959-8049(97)84398-5",
      "volume": "33",
      "year": "1997"
    },
    {
      "author": "T Peelen",
      "first-page": "1041",
      "journal-title": "Am J Hum Genet",
      "key": "38_CR130",
      "unstructured": "Peelen T, van Vliet M, Petrij-Bosch A et al (1997) A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 60:1041–1049",
      "volume": "60",
      "year": "1997"
    },
    {
      "DOI": "10.1155/1999/241046",
      "author": "K Claes",
      "doi-asserted-by": "crossref",
      "first-page": "69",
      "journal-title": "Dis Markers",
      "key": "38_CR131",
      "unstructured": "Claes K, Machackova E, De Vos M, et al (1999) Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A\u003eG. Dis Markers 15:69–73",
      "volume": "15",
      "year": "1999"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201151",
      "author": "MP Zeegers",
      "doi-asserted-by": "publisher",
      "first-page": "591",
      "journal-title": "Eur J Hum Genet",
      "key": "38_CR132",
      "unstructured": "Zeegers MP, van Poppel F, Vlietinck R et al (2004) Founder mutations among the Dutch. Eur J Hum Genet 12:591–600. doi: 10.1038/sj.ejhg.5201151",
      "volume": "12",
      "year": "2004"
    },
    {
      "DOI": "10.1016/s0959-8049(01)00244-1",
      "author": "LC Verhoog",
      "doi-asserted-by": "publisher",
      "first-page": "2082",
      "journal-title": "Eur J Cancer",
      "key": "38_CR133",
      "unstructured": "Verhoog LC, van den Ouweland AM, Berns E et al (2001) Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families. Eur J Cancer 37:2082–2090. doi: 10.1016/s0959-8049(01)00244-1",
      "volume": "37",
      "year": "2001"
    },
    {
      "DOI": "10.1086/301880",
      "author": "P Huusko",
      "doi-asserted-by": "publisher",
      "first-page": "1544",
      "journal-title": "Am J Hum Genet",
      "key": "38_CR134",
      "unstructured": "Huusko P, Pääkkönen K, Launonen V et al (1998) Evidence of founder mutations in Finnish BRCA1 and BRCA2 families. Am J Hum Genet 62:1544–1548. doi: 10.1086/301880",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1023/B:FAME.0000026819.44213.df",
      "author": "D Muller",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "journal-title": "Fam Cancer",
      "key": "38_CR135",
      "unstructured": "Muller D, Bonaiti-Pellié C, Abecassis J et al (2004) BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect. Fam Cancer 3:15–20. doi: 10.1023/B:FAME.0000026819.44213.df",
      "volume": "3",
      "year": "2004"
    },
    {
      "author": "D Stoppa-Lyonnet",
      "first-page": "1021",
      "journal-title": "Am J Hum Genet",
      "key": "38_CR136",
      "unstructured": "Stoppa-Lyonnet D, Laurent-Puig P, Essioux L et al (1997) BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am J Hum Genet 60:1021–1030",
      "volume": "60",
      "year": "1997"
    },
    {
      "DOI": "10.1002/(SICI)1097-0215(20000601)86:5\u003c737::AID-IJC21\u003e3.0.CO;2-1",
      "author": "M Looij Van Der",
      "doi-asserted-by": "crossref",
      "first-page": "737",
      "journal-title": "Int J cancer",
      "key": "38_CR137",
      "unstructured": "Van Der Looij M, Szabo C, Besznyak I et al (2000) Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int J cancer 86:737–740",
      "volume": "86",
      "year": "2000"
    },
    {
      "author": "S Thorlacius",
      "first-page": "1079",
      "journal-title": "Am J Hum Genet",
      "key": "38_CR138",
      "unstructured": "Thorlacius S, Sigurdsson S, Bjarnadottir H et al (1997) Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60:1079–1084",
      "volume": "60",
      "year": "1997"
    },
    {
      "author": "G Johannesdottir",
      "first-page": "3663",
      "journal-title": "Cancer Res",
      "key": "38_CR139",
      "unstructured": "Johannesdottir G, Gudmundsson J, Bergthorsson JT et al (1996) High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res 56:3663–3665",
      "volume": "56",
      "year": "1996"
    },
    {
      "DOI": "10.1186/1471-2407-7-132",
      "author": "G Palomba",
      "doi-asserted-by": "publisher",
      "first-page": "132",
      "journal-title": "BMC Cancer",
      "key": "38_CR140",
      "unstructured": "Palomba G, Cossu A, Friedman E et al (2007) Origin and distribution of the BRCA2-8765delAG mutation in breast cancer. BMC Cancer 7:132. doi: 10.1186/1471-2407-7-132",
      "volume": "7",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.bjc.6600840",
      "author": "TSIB Consortium",
      "doi-asserted-by": "publisher",
      "first-page": "1256",
      "journal-title": "Br J Cancer",
      "key": "38_CR141",
      "unstructured": "Scottish/Northern Irish BRCAI/BRCA2 Consortium TSIB (2003) BRCA1 and BRCA2 mutations in Scotland and Northern Ireland. Br J Cancer 88:1256–1262. doi: 10.1038/sj.bjc.6600840",
      "volume": "88",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0959-8049(01)00299-4",
      "author": "P Møller",
      "doi-asserted-by": "publisher",
      "first-page": "2428",
      "journal-title": "Eur J Cancer",
      "key": "38_CR142",
      "unstructured": "Møller P, Heimdal K, Apold J et al (2001) Genetic epidemiology of BRCA1 mutations in Norway. Eur J Cancer 37:2428–2434. doi: 10.1016/S0959-8049(01)00299-4",
      "volume": "37",
      "year": "2001"
    },
    {
      "DOI": "10.1016/s0959-8049(03)00548-3",
      "author": "K Heimdal",
      "doi-asserted-by": "publisher",
      "first-page": "2205",
      "journal-title": "Eur J Cancer",
      "key": "38_CR143",
      "unstructured": "Heimdal K, Maehle L, Apold J et al (2003) The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer. Eur J Cancer 39:2205–2213. doi: 10.1016/s0959-8049(03)00548-3",
      "volume": "39",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s13353-011-0040-6",
      "author": "I Brozek",
      "doi-asserted-by": "publisher",
      "first-page": "325",
      "journal-title": "J Appl Genet",
      "key": "38_CR144",
      "unstructured": "Brozek I, Cybulska C, Ratajska M et al (2011) Prevalence of the most frequent BRCA1 mutations in Polish population. J Appl Genet 52:325–330. doi: 10.1007/s13353-011-0040-6",
      "volume": "52",
      "year": "2011"
    },
    {
      "DOI": "10.1086/302922",
      "author": "B Górski",
      "doi-asserted-by": "publisher",
      "first-page": "1963",
      "journal-title": "Am J Hum Genet",
      "key": "38_CR145",
      "unstructured": "Górski B, Byrski T, Huzarski T et al (2000) Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66:1963–1968. doi: 10.1086/302922",
      "volume": "66",
      "year": "2000"
    },
    {
      "DOI": "10.1200/JCO.2006.06.9443",
      "author": "PM Machado",
      "doi-asserted-by": "publisher",
      "first-page": "2027",
      "journal-title": "J Clin Oncol",
      "key": "38_CR146",
      "unstructured": "Machado PM, Brandao RD, Cavaco BM et al (2007) Screening for a BRCA2 rearrangement in high-risk breast/ovarian Cancer families: evidence for a founder effect and analysis of the associated phenotypes. J Clin Oncol 25:2027–2034. doi: 10.1200/JCO.2006.06.9443",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s10549-008-9978-4",
      "author": "A Peixoto",
      "doi-asserted-by": "publisher",
      "first-page": "31",
      "journal-title": "Breast Cancer Res Treat",
      "key": "38_CR147",
      "unstructured": "Peixoto A, Santos C, Rocha P et al (2009) The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal. Breast Cancer Res Treat 114:31–38. doi: 10.1007/s10549-008-9978-4",
      "volume": "114",
      "year": "2009"
    },
    {
      "DOI": "10.1186/1897-4287-4-4-193",
      "author": "N Krylova",
      "doi-asserted-by": "publisher",
      "first-page": "193",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "38_CR148",
      "unstructured": "Krylova N, Lobeiko OS, Sokolenko AP et al (2006) BRCA1 4153delA founder mutation in Russian ovarian cancer patients. Hered Cancer Clin Pract 4:193. doi: 10.1186/1897-4287-4-4-193",
      "volume": "4",
      "year": "2006"
    },
    {
      "DOI": "10.1186/bcr1282",
      "author": "P Pohlreich",
      "doi-asserted-by": "publisher",
      "first-page": "R728-36",
      "journal-title": "Breast Cancer Res",
      "key": "38_CR149",
      "unstructured": "Pohlreich P, Zikan M, Stribrna J et al (2005) High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area. Breast Cancer Res 7:R728-36. doi: 10.1186/bcr1282",
      "volume": "7",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.ejhg.5200886",
      "author": "M Krajc",
      "doi-asserted-by": "publisher",
      "first-page": "879",
      "journal-title": "Eur J Hum Genet",
      "key": "38_CR150",
      "unstructured": "Krajc M, De Grève J, Goelen G, Teugels E (2002) BRCA2 founder mutation in Slovenian breast cancer families. Eur J Hum Genet 10:879–882. doi: 10.1038/sj.ejhg.5200886",
      "volume": "10",
      "year": "2002"
    },
    {
      "DOI": "10.1186/1471-2350-9-83",
      "author": "M Krajc",
      "doi-asserted-by": "publisher",
      "first-page": "83",
      "journal-title": "BMC Med Genet",
      "key": "38_CR151",
      "unstructured": "Krajc M, Teugels E, Zgajnar J et al (2008) Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families. BMC Med Genet 9:83. doi: 10.1186/1471-2350-9-83",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1002/humu.1136",
      "author": "A Vega",
      "doi-asserted-by": "publisher",
      "first-page": "520",
      "journal-title": "Hum Mutat",
      "key": "38_CR152",
      "unstructured": "Vega A, Campos B, Bressac-De-Paillerets B et al (2001) The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat 17:520–521. doi: 10.1002/humu.1136",
      "volume": "17",
      "year": "2001"
    },
    {
      "DOI": "10.1186/1471-2407-13-243",
      "author": "P Blay",
      "doi-asserted-by": "publisher",
      "first-page": "243",
      "journal-title": "BMC Cancer",
      "key": "38_CR153",
      "unstructured": "Blay P, Santamaría I, Pitiot AS et al (2013) Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain). BMC Cancer 13:243. doi: 10.1186/1471-2407-13-243",
      "volume": "13",
      "year": "2013"
    },
    {
      "DOI": "10.1038/sj.ejhg.5200704",
      "author": "A Bergman",
      "doi-asserted-by": "publisher",
      "first-page": "787",
      "journal-title": "Eur J Hum Genet",
      "key": "38_CR154",
      "unstructured": "Bergman A, Einbeigi Z, Olofsson U et al (2001) The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation. Eur J Hum Genet 9:787–793. doi: 10.1038/sj.ejhg.5200704",
      "volume": "9",
      "year": "2001"
    },
    {
      "DOI": "10.1007/s10689-004-5812-2",
      "author": "A Bergman",
      "doi-asserted-by": "publisher",
      "first-page": "89",
      "journal-title": "Fam Cancer",
      "key": "38_CR155",
      "unstructured": "Bergman A, Flodin A, Engwall Y et al (2005) A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques. Fam Cancer 4:89–96. doi: 10.1007/s10689-004-5812-2",
      "volume": "4",
      "year": "2005"
    }
  ],
  "reference-count": 155,
  "references-count": 155,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-017-0038-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Mutations in context: implications of BRCA testing in diverse populations"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}